Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	KLHDC1 A1CF PRAMEF5 PRAMEF9 NMNAT1 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 PRAMEF6	6.89e-13	95	93	11	GO:0140767
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	KLHDC1 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 PRAMEF6	1.54e-10	82	93	9	GO:1990756
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	2.09e-07	55	93	6	GO:0042974
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	SHANK1 SRRT KLHDC1 A1CF PRAMEF5 PRAMEF9 NMNAT1 PRAMEF15 LRRK2 NUP98 MED14 NBN PRAMEF4 CTNNB1 KLHDC10 PRAMEF26 PRAMEF27 TP53BP1 PRAMEF6	1.34e-06	1160	93	19	GO:0030674
GeneOntologyMolecularFunction	nuclear receptor binding	PRAMEF5 PRAMEF15 MED14 PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 PRAMEF6	2.63e-06	187	93	8	GO:0016922
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	PRAMEF5 PRAMEF15 MED14 NBN PRAMEF4 CTNNB1 USF1 USF2 PRAMEF26 PRAMEF27 TP53 TP53BP1 PRAMEF6	2.94e-06	582	93	13	GO:0140297
GeneOntologyMolecularFunction	molecular adaptor activity	SHANK1 SRRT KLHDC1 A1CF PRAMEF5 PRAMEF9 NMNAT1 PRAMEF15 ITSN2 LRRK2 NUP98 MED14 NBN PRAMEF4 CTNNB1 KLHDC10 PRAMEF26 PRAMEF27 TP53BP1 PRAMEF6	3.38e-06	1356	93	20	GO:0060090
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	PRAMEF5 PRAMEF15 MED14 PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 TP53BP1 PRAMEF6	2.44e-05	417	93	10	GO:0061629
GeneOntologyMolecularFunction	transcription factor binding	PRAMEF5 PRAMEF15 MED14 NBN PRAMEF4 CTNNB1 USF1 USF2 PRAMEF26 PRAMEF27 TP53 TP53BP1 PRAMEF6	4.52e-05	753	93	13	GO:0008134
GeneOntologyBiologicalProcess	positive regulation of synaptic vesicle recycling	PLAA ABCA13 LRRK2	5.76e-05	17	93	3	GO:1903423
GeneOntologyBiologicalProcess	oogenesis	PRAMEF5 PRAMEF15 ZNF830 PRAMEF4 CTNNB1 PRAMEF6	7.53e-05	156	93	6	GO:0048477
GeneOntologyBiologicalProcess	oocyte development	PRAMEF5 PRAMEF15 PRAMEF4 CTNNB1 PRAMEF6	8.56e-05	99	93	5	GO:0048599
GeneOntologyBiologicalProcess	stem cell population maintenance	SRRT PRAMEF5 PRAMEF15 MED14 PRAMEF4 CTNNB1 PRAMEF6	9.91e-05	237	93	7	GO:0019827
GeneOntologyBiologicalProcess	oocyte differentiation	PRAMEF5 PRAMEF15 PRAMEF4 CTNNB1 PRAMEF6	1.03e-04	103	93	5	GO:0009994
GeneOntologyBiologicalProcess	maintenance of cell number	SRRT PRAMEF5 PRAMEF15 MED14 PRAMEF4 CTNNB1 PRAMEF6	1.13e-04	242	93	7	GO:0098727
GeneOntologyBiologicalProcess	late viral transcription	USF1 USF2	1.20e-04	4	93	2	GO:0019086
GeneOntologyBiologicalProcess	somatic stem cell population maintenance	PRAMEF5 PRAMEF15 MED14 PRAMEF4 PRAMEF6	1.29e-04	108	93	5	GO:0035019
GeneOntologyBiologicalProcess	negative regulation of cell differentiation	PRTG PRAMEF25 PRAMEF5 PRAMEF9 IPO7 PRAMEF15 NBN PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 PRAMEF6	1.48e-04	875	93	13	GO:0045596
GeneOntologyBiologicalProcess	negative regulation of apoptotic process	PRAMEF25 PRAMEF5 PRAMEF9 NMNAT1 GCLM PRAMEF15 LRRK2 ABCC9 ZNF830 PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 PRAMEF6	1.58e-04	1133	93	15	GO:0043066
GeneOntologyBiologicalProcess	blastocyst development	PRAMEF5 PRAMEF15 NBN ZNF830 PRAMEF4 PRAMEF6	1.60e-04	179	93	6	GO:0001824
GeneOntologyBiologicalProcess	negative regulation of programmed cell death	PRAMEF25 PRAMEF5 PRAMEF9 NMNAT1 GCLM PRAMEF15 LRRK2 ABCC9 ZNF830 PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 PRAMEF6	2.26e-04	1171	93	15	GO:0043069
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 PRAMEF6	3.08e-11	47	93	8	GO:0031462
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	KLHDC1 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 PRAMEF6	4.41e-07	212	93	9	GO:0031461
GeneOntologyCellularComponent	ubiquitin ligase complex	KLHDC1 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 PRAMEF6	2.73e-05	352	93	9	GO:0000151
GeneOntologyCellularComponent	synaptic membrane	SHANK1 MPP4 ITSN2 SLITRK5 GPR156 ADGRL1 SLITRK3 GRIN2C CTNNB1 ATP2B3	2.67e-04	583	93	10	GO:0097060
GeneOntologyCellularComponent	acrosomal vesicle	PRAMEF5 VEZT PRAMEF15 ABCC9 PRAMEF4 PRAMEF6	3.18e-04	206	93	6	GO:0001669
MousePheno	abnormal spermatogonia proliferation	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	1.49e-07	47	73	6	MP:0002685
MousePheno	abnormal tail morphology	PHEX RPL27A PARP4 PRAMEF5 PRAMEF15 PRAMEF4 CTNNB1 USF2 SVEP1 TP53 PRAMEF6	7.12e-06	403	73	11	MP:0002111
MousePheno	abnormal cell proliferation	RPL27A A1CF CD4 CD5 PRAMEF5 GCLM PRAMEF15 NUP98 NBN ZNF830 PRAMEF4 CTNNB1 ESPL1 PRAMEF26 IL23A PRAMEF27 TP53 TP53BP1 PRAMEF6	2.49e-05	1294	73	19	MP:0000350
MousePheno	abnormal male germ cell apoptosis	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 TP53 PRAMEF6	3.06e-05	236	73	8	MP:0008280
MousePheno	enlarged urinary bladder	PRAMEF5 NHSL2 MICAL2 PRAMEF15 PRAMEF4 PRAMEF6	3.10e-05	116	73	6	MP:0011874
MousePheno	abnormal male germ cell physiology	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 TP53 PRAMEF6	3.88e-05	244	73	8	MP:0020362
MousePheno	increased mortality induced by gamma-irradiation	RPL27A NBN TP53 TP53BP1	3.97e-05	37	73	4	MP:0001658
MousePheno	abnormal urinary bladder morphology	PRAMEF5 IPO7 NHSL2 MICAL2 PRAMEF15 SLITRK5 PRAMEF4 PRAMEF6	4.23e-05	247	73	8	MP:0000538
MousePheno	absent gametes	PRAMEF5 KCTD19 PRAMEF15 NBN PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	5.45e-05	256	73	8	MP:0001117
MousePheno	increased male germ cell apoptosis	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	5.67e-05	189	73	7	MP:0014052
MousePheno	abnormal jejunum morphology	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	5.99e-05	41	73	4	MP:0004002
MousePheno	abnormal germ cell physiology	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 TP53 PRAMEF6	7.33e-05	267	73	8	MP:0020363
MousePheno	abnormal vitreous body morphology	SHANK1 PARP4 PRAMEF5 PRAMEF15 PRAMEF4 KLHDC10 PRAMEF26 PRAMEF27 TP53 PRAMEF6	7.36e-05	429	73	10	MP:0002699
MousePheno	increased mortality induced by ionizing radiation	RPL27A NBN TP53 TP53BP1	1.42e-04	51	73	4	MP:0003992
MousePheno	increased apoptosis	IL34 SRRT PRTG PRAMEF5 KCTD19 GCLM PRAMEF15 LRRK2 NBN PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 PRAMEF6	1.84e-04	1008	73	15	MP:0006042
MousePheno	abnormal mortality induced by ionizing radiation	RPL27A NBN TP53 TP53BP1	1.91e-04	55	73	4	MP:0020149
MousePheno	abnormal lymph node morphology	IL34 CD4 PRAMEF5 IPO7 NHSL2 MICAL2 PRAMEF15 SLITRK5 PRAMEF4 CTNNB1 TP53 PRAMEF6	1.99e-04	683	73	12	MP:0002339
MousePheno	increased cell death	IL34 SRRT PRTG PRAMEF5 KCTD19 GCLM PRAMEF15 LRRK2 NBN PRAMEF4 CTNNB1 PRAMEF26 PRAMEF27 TP53 PRAMEF6	2.08e-04	1019	73	15	MP:0012556
MousePheno	abnormal response to radiation	RPL27A NBN TP53 TP53BP1	2.19e-04	57	73	4	MP:0012734
MousePheno	azoospermia	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	2.77e-04	244	73	7	MP:0005159
MousePheno	abnormal foot pad morphology	RPL27A CTNNB1 TP53	3.26e-04	26	73	3	MP:0000574
MousePheno	abnormal duodenum morphology	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	3.43e-04	64	73	4	MP:0003271
MousePheno	small kidney	PARP4 PRAMEF5 MICAL2 PRAMEF15 LRRK2 IL17RC PRAMEF4 TP53 PRAMEF6	3.53e-04	425	73	9	MP:0002989
MousePheno	abnormal coat/ hair morphology	SHANK1 KCTD19 VEZT BAZ2B ITSN2 LRRK2 SLITRK5 CTNNB1 USF2 ATP2B3 USP19 TP53 DOP1B	4.26e-04	854	73	13	MP:0000367
MousePheno	abnormal lymph node size	IL34 PRAMEF5 IPO7 NHSL2 MICAL2 PRAMEF15 SLITRK5 PRAMEF4 CTNNB1 PRAMEF6	6.37e-04	561	73	10	MP:0000701
MousePheno	decreased testis weight	PRAMEF5 KCTD19 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 TP53 PRAMEF6	6.70e-04	370	73	8	MP:0004852
Domain	PRAME_family	PRAMEF25 PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF6	2.73e-10	19	90	6	IPR026271
Domain	-	LRRC39 PRAMEF25 PRAMEF5 PRAMEF15 LRRK2 SLITRK5 SLITRK3 PRAMEF4 PRAMEF27 PRAMEF6	3.32e-06	321	90	10	3.80.10.10
Domain	L_dom-like	LRRC39 PRAMEF25 PRAMEF5 PRAMEF15 LRRK2 SLITRK5 SLITRK3 PRAMEF4 PRAMEF27 PRAMEF6	4.01e-06	328	90	10	IPR032675
Domain	BRCT	PARP4 NBN TP53BP1	9.92e-05	19	90	3	PF00533
Domain	BRCT	PARP4 NBN TP53BP1	1.56e-04	22	90	3	SM00292
Domain	-	PARP4 NBN TP53BP1	1.79e-04	23	90	3	3.40.50.10190
Domain	BRCT	PARP4 NBN TP53BP1	2.60e-04	26	90	3	PS50172
Domain	BRCT_dom	PARP4 NBN TP53BP1	3.25e-04	28	90	3	IPR001357
Domain	-	PARP4 INTS6 MDN1 SVEP1	4.48e-04	74	90	4	3.40.50.410
Domain	VWFA	PARP4 INTS6 MDN1 SVEP1	6.62e-04	82	90	4	PS50234
Domain	VWA	PARP4 INTS6 MDN1 SVEP1	7.25e-04	84	90	4	SM00327
Domain	Leu-rich_rpt_4	LRRC39 LRRK2	1.01e-03	10	90	2	IPR025875
Domain	LRR_4	LRRC39 LRRK2	1.01e-03	10	90	2	PF12799
Domain	VWF_A	PARP4 INTS6 MDN1 SVEP1	1.34e-03	99	90	4	IPR002035
Domain	VWA	PARP4 INTS6 SVEP1	2.49e-03	56	90	3	PF00092
Domain	Pyr_redox_2	MICAL2 ETFDH	3.72e-03	19	90	2	PF07992
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	2.39e-11	22	94	6	31729367
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	5.63e-11	25	94	6	37451217
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	1.19e-10	28	94	6	25089626
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	5.05e-10	35	94	6	19389355
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF6	1.94e-09	20	94	5	26694250
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.16e-07	17	94	4	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.16e-07	17	94	4	37781892
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.49e-07	18	94	4	39181896
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.49e-07	18	94	4	29731491
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.49e-07	18	94	4	14675769
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.49e-07	18	94	4	23894331
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.49e-07	18	94	4	12890732
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.88e-07	19	94	4	28604677
Pubmed	53BP1 facilitates long-range DNA end-joining during V(D)J recombination.	NBN TP53 TP53BP1	1.90e-07	5	94	3	18931658
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	2.35e-07	20	94	4	21425410
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	2.35e-07	20	94	4	16580637
Pubmed	Cracking the egg: molecular dynamics and evolutionary aspects of the transition from the fully grown oocyte to embryo.	PRAMEF5 PLAA MPP4 GCLM PRAMEF15 PRAMEF4 CPSF2 USF1 PRAMEF6	2.65e-07	326	94	9	17015433
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	4.26e-07	23	94	4	19480014
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	6.06e-07	25	94	4	12620990
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	7.15e-07	26	94	4	18500982
Pubmed	53BP1 promotes ATM activity through direct interactions with the MRN complex.	NBN TP53 TP53BP1	1.06e-06	8	94	3	20010693
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.30e-06	30	94	4	38786026
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.70e-06	32	94	4	37889087
Pubmed	Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.	NBN TP53 TP53BP1	3.11e-06	11	94	3	16400328
Pubmed	Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network.	CD4 CTNNB1 TP53	6.81e-06	14	94	3	23762317
Pubmed	Interaction of upstream stimulatory factor proteins with an E-box located within the human CYP1A2 5'-flanking gene contributes to basal transcriptional gene activation.	USF1 USF2	7.23e-06	2	94	2	12663044
Pubmed	Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.	CTNNB1 TP53	7.23e-06	2	94	2	20129645
Pubmed	Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation.	IL34 TP53	7.23e-06	2	94	2	39321806
Pubmed	CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.	CD5 TP53	7.23e-06	2	94	2	31359442
Pubmed	Cigarette smoking, TP53 Arg72Pro, TP53BP1 Asp353Glu and the risk of lung cancer in a Japanese population.	TP53 TP53BP1	7.23e-06	2	94	2	20372852
Pubmed	Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells.	USF1 USF2	7.23e-06	2	94	2	8127680
Pubmed	Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.	CTNNB1 TP53	7.23e-06	2	94	2	20959480
Pubmed	Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.	TP53 TP53BP1	7.23e-06	2	94	2	12110597
Pubmed	Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.	CTNNB1 TP53	7.23e-06	2	94	2	21061181
Pubmed	Deletion of beta-catenin impairs T cell development.	CD4 CTNNB1	7.23e-06	2	94	2	14608382
Pubmed	Beta-catenin and p53 expression in topographic compartments of colorectal cancer and its prognostic value following surgery.	CTNNB1 TP53	7.23e-06	2	94	2	29146051
Pubmed	Cardiomyocyte-specific deletion of β-catenin protects mouse hearts from ventricular arrhythmias after myocardial infarction.	A1CF CTNNB1	7.23e-06	2	94	2	34489488
Pubmed	Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice.	USF1 USF2	7.23e-06	2	94	2	9520440
Pubmed	Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse.	USF1 USF2	7.23e-06	2	94	2	7774954
Pubmed	Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.	NBN TP53	7.23e-06	2	94	2	18593981
Pubmed	Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1).	USF1 USF2	7.23e-06	2	94	2	18845576
Pubmed	Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription.	TP53 TP53BP1	7.23e-06	2	94	2	25837623
Pubmed	Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease.	USF1 USF2	7.23e-06	2	94	2	16870626
Pubmed	Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population.	TP53 TP53BP1	7.23e-06	2	94	2	16314399
Pubmed	[Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].	TP53 TP53BP1	7.23e-06	2	94	2	17927872
Pubmed	Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription.	USF1 USF2	7.23e-06	2	94	2	15242350
Pubmed	Separase loss of function cooperates with the loss of p53 in the initiation and progression of T- and B-cell lymphoma, leukemia and aneuploidy in mice.	ESPL1 TP53	7.23e-06	2	94	2	21799785
Pubmed	Beta-catenin expression results in p53-independent DNA damage and oncogene-induced senescence in prelymphomagenic thymocytes in vivo.	CTNNB1 TP53	7.23e-06	2	94	2	18160717
Pubmed	H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression.	USF1 USF2	7.23e-06	2	94	2	20180799
Pubmed	The dual role of helix-loop--helix-zipper protein USF in ribosomal RNA gene transcription in vivo.	USF1 USF2	7.23e-06	2	94	2	9053857
Pubmed	Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese.	TP53 TP53BP1	7.23e-06	2	94	2	24316395
Pubmed	Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity.	LRRK2 TP53	7.23e-06	2	94	2	27914807
Pubmed	p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition.	TP53 TP53BP1	7.23e-06	2	94	2	8910340
Pubmed	Polymorphic TP53BP1 and TP53 gene interactions associated with risk of squamous cell carcinoma of the head and neck.	TP53 TP53BP1	7.23e-06	2	94	2	17634560
Pubmed	Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter.	USF1 USF2	7.23e-06	2	94	2	7852331
Pubmed	Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.	CTNNB1 TP53	7.23e-06	2	94	2	17962810
Pubmed	Structural insight into p53 recognition by the 53BP1 tandem Tudor domain.	TP53 TP53BP1	7.23e-06	2	94	2	20307547
Pubmed	Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling.	TP53 TP53BP1	7.23e-06	2	94	2	18840612
Pubmed	Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection.	CTNNB1 TP53	7.23e-06	2	94	2	26341700
Pubmed	53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.	TP53 TP53BP1	7.23e-06	2	94	2	16492765
Pubmed	Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.	CTNNB1 TP53	7.23e-06	2	94	2	18455580
Pubmed	53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice.	TP53 TP53BP1	7.23e-06	2	94	2	16260621
Pubmed	p53 requires the stress sensor USF1 to direct appropriate cell fate decision.	USF1 TP53	7.23e-06	2	94	2	24831529
Pubmed	Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.	CTNNB1 TP53	7.23e-06	2	94	2	20963515
Pubmed	Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.	NBN TP53	7.23e-06	2	94	2	37296499
Pubmed	Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.	CTNNB1 TP53	7.23e-06	2	94	2	18313840
Pubmed	Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.	NBN TP53	7.23e-06	2	94	2	19151620
Pubmed	An essential function for NBS1 in the prevention of ataxia and cerebellar defects.	NBN TP53	7.23e-06	2	94	2	15821748
Pubmed	Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms.	USF1 USF2	7.23e-06	2	94	2	8576131
Pubmed	Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose.	USF1 USF2	7.23e-06	2	94	2	9685363
Pubmed	Mutations in the p53 tumor suppressor gene and early onset breast cancer.	TP53 TP53BP1	7.23e-06	2	94	2	12170762
Pubmed	Beta-catenin signaling mediates CD4 expression on mature CD8+ T cells.	CD4 CTNNB1	7.23e-06	2	94	2	20631314
Pubmed	Purification, crystallization and preliminary X-ray analysis of the BRCT domains of human 53BP1 bound to the p53 tumour suppressor.	TP53 TP53BP1	7.23e-06	2	94	2	12351827
Pubmed	Negative regulation of CD4 lineage development and responses by CD5.	CD4 CD5	7.23e-06	2	94	2	10586041
Pubmed	53BP1 Goes Back to Its p53 Roots.	TP53 TP53BP1	7.23e-06	2	94	2	27716486
Pubmed	[USF as a key regulatory element of gene expression].	USF1 USF2	7.23e-06	2	94	2	16386222
Pubmed	USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells.	USF1 USF2	7.23e-06	2	94	2	17379962
Pubmed	Mbd3, a component of the NuRD co-repressor complex, is required for development of pluripotent cells.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	7.48e-06	46	94	4	17287250
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.05e-05	50	94	4	31806660
Pubmed	Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array.	PARP4 NBN TP53 TP53BP1	1.54e-05	55	94	4	19536092
Pubmed	ZAR1 and ZAR2 are required for oocyte meiotic maturation by regulating the maternal transcriptome and mRNA translational activation.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	1.90e-05	58	94	4	31598710
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	2.03e-05	59	94	4	11279525
Pubmed	Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.	CTNNB1 TP53	2.16e-05	3	94	2	26553052
Pubmed	DNA replication and sister chromatid cohesion 1 promotes breast carcinoma progression by modulating the Wnt/β-catenin signaling and p53 protein.	CTNNB1 TP53	2.16e-05	3	94	2	33184243
Pubmed	Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.	CTNNB1 TP53	2.16e-05	3	94	2	24885829
Pubmed	Upregulation of gamma-catenin compensates for the loss of beta-catenin in adult cardiomyocytes.	A1CF CTNNB1	2.16e-05	3	94	2	16936006
Pubmed	Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter.	USF1 USF2	2.16e-05	3	94	2	21813151
Pubmed	Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.	TP53 TP53BP1	2.16e-05	3	94	2	14978302
Pubmed	The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation.	TP53 TP53BP1	2.16e-05	3	94	2	15611139
Pubmed	Distinct kinetics of DNA repair protein accumulation at DNA lesions and cell cycle-dependent formation of γH2AX- and NBS1-positive repair foci.	NBN TP53BP1	2.16e-05	3	94	2	26482424
Pubmed	Upstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.	USF1 USF2	2.16e-05	3	94	2	23653383
Pubmed	Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.	CTNNB1 TP53	2.16e-05	3	94	2	26614845
Pubmed	Embryonic Stem Cell Differentiation Is Regulated by SET through Interactions with p53 and β-Catenin.	CTNNB1 TP53	2.16e-05	3	94	2	33296674
Pubmed	Molecular basis for the tissue specificity of β-catenin oncogenesis.	CTNNB1 TP53	2.16e-05	3	94	2	22689057
Pubmed	Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma.	CTNNB1 TP53	2.16e-05	3	94	2	32213661
Pubmed	Altered expressions of Notch-1 signaling proteins and beta-catenin in progression of carcinoma in situ into squamous carcinoma of uterine cervix.	CTNNB1 TP53	2.16e-05	3	94	2	28195086
Pubmed	p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.	A1CF TP53	2.16e-05	3	94	2	17334357
Pubmed	Conventional colon adenomas harbor various disturbances in microsatellite stability and contain micro-serrated foci with microsatellite instability.	CTNNB1 TP53	2.16e-05	3	94	2	28234922
Pubmed	ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy.	CTNNB1 TP53	2.16e-05	3	94	2	23516071
Pubmed	GPR56 C-terminal fragment mediates signal received by N-terminal fragment of another adhesion GPCR Latrophilin1 in neurons.	ADGRG1 ADGRL1	2.16e-05	3	94	2	36453010
Interaction	PRAMEF4 interactions	PRAMEF5 PRAMEF9 PRAMEF4	8.61e-08	3	90	3	int:PRAMEF4
Interaction	PRAMEF5 interactions	PRAMEF5 PRAMEF15 PRAMEF4	4.75e-06	8	90	3	int:PRAMEF5
Interaction	PRAMEF15 interactions	PRAMEF5 PRAMEF15	1.97e-05	2	90	2	int:PRAMEF15
Cytoband	1p36.21	PRAMEF25 PRAMEF5 PRAMEF9 AADACL3 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF6	8.04e-13	63	94	8	1p36.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	PRAMEF25 PRAMEF5 PRAMEF9 NMNAT1 AADACL3 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	1.43e-06	681	94	10	chr1p36
GeneFamily	PRAME family	PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	9.65e-15	24	63	8	686
Coexpression	KOHOUTEK_CCNT2_TARGETS	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	4.44e-07	81	93	6	MM938
Coexpression	GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN	PHEX PLAA LRRK2 CPSF2 PKHD1L1 TSPAN5 RNF111	1.10e-06	150	93	7	M6883
Coexpression	INGRAM_SHH_TARGETS_UP	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 TSPAN5 PRAMEF6	1.43e-06	156	93	7	MM550
Coexpression	YAMAZAKI_TCEB3_TARGETS_DN	PRAMEF5 MDN1 GCLM PRAMEF15 PRAMEF4 PRAMEF26 PRAMEF27 PRAMEF6	1.78e-06	232	93	8	MM1019
Coexpression	KINNEY_DNMT1_METHYLATION_TARGETS	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	6.35e-06	34	93	4	MM955
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	MDN1 IPO7 BAZ2B ITSN2 NUP98 NBN TSPAN5 DOP1B ZNF292	4.22e-05	466	93	9	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MDN1 IPO7 BAZ2B MICAL2 ITSN2 NUP98 NBN KLHDC10 TSPAN5 TP53BP1 DOP1B ZNF292	5.02e-05	856	93	12	M4500
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	PRAMEF5 PRAMEF15 PRAMEF4 PRAMEF6	5.08e-05	57	93	4	MM1262
Coexpression	GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	LRRC39 CFAP52 NMNAT1 NIPSNAP3B ATP2B3 ZNF292	7.61e-05	198	93	6	M7916
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRTG A1CF ABCA13 PKHD1L1 ATP2B3 PDE11A	1.24e-06	162	94	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF6	1.61e-06	93	94	5	3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A	WSB1 BAZ2B ETFDH NUP98 IL17RC KLHDC10 TP53BP1 ZNF292	1.11e-06	196	90	8	1767_DN
Disease	colorectal cancer (biomarker_via_orthology)	CTNNB1 TP53	1.19e-04	6	84	2	DOID:9256 (biomarker_via_orthology)
Disease	Adenoma, Microcystic	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205648
Disease	Adenoma, Monomorphic	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205649
Disease	Adenoma, Basal Cell	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205646
Disease	Follicular adenoma	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205647
Disease	Papillary adenoma	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205650
Disease	Adenoma, Trabecular	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0205651
Disease	Adenoma	CTNNB1 ATP2B3 TP53	1.48e-04	36	84	3	C0001430
Disease	Brain Neoplasms	CYP2C9 CTNNB1 TP53	1.89e-04	39	84	3	C0006118
Disease	Acute erythroleukemia - M6a subtype	NUP98 TP53	2.22e-04	8	84	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	NUP98 TP53	2.22e-04	8	84	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	NUP98 TP53	2.22e-04	8	84	2	C2930977
Disease	Acute erythroleukemia	NUP98 TP53	2.22e-04	8	84	2	C2930974
Disease	HEPATOCELLULAR CARCINOMA	CTNNB1 TP53	2.85e-04	9	84	2	114550
Disease	Adult Hepatocellular Carcinoma	CTNNB1 TP53	2.85e-04	9	84	2	C0279607
Disease	Hepatocellular carcinoma	CTNNB1 TP53	2.85e-04	9	84	2	cv:C2239176
Disease	Glioma	CTNNB1 TP53	2.85e-04	9	84	2	cv:C0017638
Disease	stroke outcome severity measurement	A1CF PLAA CPSF2 ZNF292	3.21e-04	114	84	4	EFO_0009603
Disease	Adrenal Gland Neoplasms	CTNNB1 TP53	4.33e-04	11	84	2	C0001624
Disease	Adrenal Cancer	CTNNB1 TP53	4.33e-04	11	84	2	C0750887
Disease	gastric adenocarcinoma (is_implicated_in)	ABCA13 TP53	4.33e-04	11	84	2	DOID:3717 (is_implicated_in)
Disease	Hereditary Breast and Ovarian Cancer Syndrome	NBN TP53	7.13e-04	14	84	2	C0677776
Disease	Colonic Neoplasms	PARP4 CTNNB1 TP53 TP53BP1	9.48e-04	152	84	4	C0009375
Disease	Malignant tumor of colon	PARP4 CTNNB1 TP53 TP53BP1	1.12e-03	159	84	4	C0007102
Disease	Endometrioma	RASL11A LRRK2 MED14 ABCC9	1.17e-03	161	84	4	C0269102
Disease	Endometriosis	RASL11A LRRK2 MED14 ABCC9	1.17e-03	161	84	4	C0014175
Disease	Colorectal Neoplasms	ABCA13 RASL11A CTNNB1 TP53 ZNF292	1.19e-03	277	84	5	C0009404
Disease	Hemangiosarcoma	CTNNB1 TP53	1.19e-03	18	84	2	C0018923
Disease	Adrenocortical carcinoma	CTNNB1 TP53	1.19e-03	18	84	2	C0206686
Disease	Nerve Degeneration	CD4 LRRK2 CTNNB1	1.74e-03	83	84	3	C0027746
Disease	Giant Cell Glioblastoma	SRRT TP53 TP53BP1	1.80e-03	84	84	3	C0334588
Disease	Colorectal cancer	CTNNB1 TP53	2.68e-03	27	84	2	cv:C0346629
Disease	COLORECTAL CANCER	CTNNB1 TP53	2.68e-03	27	84	2	114500
Disease	Neoplasm of the large intestine	CTNNB1 TP53	2.68e-03	27	84	2	cv:C0009404

Protein segments in the cluster

Peptide	Gene	Start	Entry
LFIQWCQDPKNSIIL	CPSF2	341	Q9P2I0
LAPQILEEICQKNNW	A1CF	446	Q9NQ94
NCTSPWVNQVAQKIK	ADGRL1	531	O94910
QVALCIQQLQKSIAW	BAZ2B	1911	Q9UIF8
DPKVQINAICSQWLP	EFL1	336	Q7Z2Z2
CIQKTLNEWSSQINP	GCLM	46	P48507
QPLPIQWKIQNSSCT	CD5	231	P06127
EIEKIWSSPNQLNCE	ABCA13	2986	Q86UQ4
AQKPWLLNATVEENI	ABCC9	756	O60706
QQRKNIPLLTWSFIC	AADACL3	236	Q5VUY0
WGQVIATIPTSQLKC	ATP2B3	1051	Q16720
LLPNWKVNVDVDSNI	CLDN20	26	P56880
QVVENLKAQALCSWT	ITSN2	896	Q9NZM3
VTEPSSKNLWEQICK	IQCK	46	Q8N0W5
QFILERKSPQTCWQV	INTS6	336	Q9UL03
NCKQWEFQPLTATRS	KCTD19	646	Q17RG1
EKWLLNLIQNECSVP	NXF3	126	Q9H4D5
TDPSQRLVQNCLWTL	CTNNB1	371	P35222
PVWQLSEKKQINVCS	NUP98	1406	P52948
LAKQVWTPQDRQCVL	MDN1	31	Q9NU22
WTVTPFVVQICKNLD	DOP1B	1536	Q9Y3R5
TLWLQRNEITCLPQT	LRRC39	226	Q96DD0
NRKIWPTECQTGQLK	CFAP52	191	Q8N1V2
SLTCQQVSPQMWQLL	IPO7	661	O95373
TREWTQLKPNNLSCD	KLHDC10	241	Q6PID8
SVLCVPIWNSNHQII	PDE11A	511	Q9HCR9
VNNLLEKISQTAPEW	COPS4	381	Q9BT78
CKEWQEQSIIPNLAR	NIPSNAP3B	106	Q9BS92
LLSAIQKAQEEPQWV	MPP4	611	Q96JB8
KRQACPNWVFQTLVI	MYRFL	616	Q96LU7
EVEVNCKWVLPILTQ	PRAMEF15	211	P0DUQ1
CIRQNTSEKQNPWTE	KIF24	206	Q5T7B8
QKEIQSCLTVWDINL	LRRK2	2486	Q5S007
QLAKTCPVQLWVDST	TP53	136	P04637
CHSVSVKWQQLNPDV	PARP4	1051	Q9UKK3
QLKWNVQFCLTIPPS	MED14	1331	O60244
VCSPTAVNTQRKLWQ	MTERF2	106	Q49AM1
LEPLNCTTISVRWQQ	PRTG	626	Q2VWP7
TCDIKDPSQNINWVV	ETFDH	591	Q16134
NLVQKWQVLSEVLSC	ESPL1	976	Q14674
KQSSVLNWQDCEVPS	IL34	181	Q6ZMJ4
SSPAWTQCQQLSQKL	IL23A	26	Q9NPF7
QPKEVQTLWCTDSQV	C1orf112	356	Q9NSG2
QLQKNLTCEVWGPTS	CD4	321	P01730
QLQPKNVTLQCVFWV	ADGRG1	336	Q9Y653
KTCINPLQVWITSAS	MDH1B	126	Q5I0G3
TTINCFIFIPQLKQW	GPR156	301	Q8NFN8
NVTTNCWKQLTHLPK	KLHDC1	281	Q8N7A1
SWLVEQCRQLGLKQP	DDX49	11	Q9Y6V7
KILSSPWIQICNNFS	CYP2C9	206	P11712
VEVNCKWVLPILTQF	PRAMEF26	116	H0Y7S4
TRLQWDIPKQCQAVI	CPT1B	516	Q92523
STNQTPALNLLWEKC	FOCAD	41	Q5VW36
QVNSSEKLQLQECLW	IL17RC	441	Q8NAC3
DIRPSKLLTWCQQQT	MICAL2	516	O94851
NQSFCPTVNLDKLWT	RPL27A	66	P46776
SLPQVVDSLSKCVQW	RASL11A	91	Q6T310
ILEEKRWPQLCSTQS	NHSL2	231	Q5HYW2
TNSQTLIPDCQKKWI	NBN	276	O60934
NLWKNIVVLCVNSLT	SLC22A23	426	A1A5C7
CVQLKNNPLSWTIIA	OVCH1	616	Q7RTY7
ENPWNCTCEIVQLKS	SLITRK3	231	O94933
EVEVNCKWVLPILTQ	PRAMEF25	211	A6NGN4
LTRPVVLWSQQDVCK	SAMD10	111	Q9BYL1
EVEVNCKWVLPILTQ	PRAMEF27	211	A3QJZ7
SQQWNDSFPVCKIVL	SVEP1	2366	Q4LDE5
NPDATIWTAKQQVLC	SHANK1	91	Q9Y566
RSVNIKEICWNLQNI	SRRT	471	Q9BXP5
EVEVNCKWVLPILTQ	PRAMEF4	211	O60810
EVNCKWVLPILTQFT	PRAMEF6	211	Q5VXH4
WQTAVTKCIPQQKND	SENP5	696	Q96HI0
WQVKLRNLIEPEQCT	USP19	346	O94966
QVCVDQWLITNKKCP	RNF111	966	Q6ZNA4
KVVELQLEENPWNCS	SLITRK5	226	O94991
VINTTQDPCSWVDKL	TMEM144	166	Q7Z5S9
EVEVNCKWVLPILTQ	PRAMEF9	211	P0DUQ2
PTVQQLQILWKAINC	PLAA	591	Q9Y263
EVNCKWVLPILTQFT	PRAMEF5	211	Q5TYX0
QETGVWKNPVLCTIL	ZNF292	156	O60281
TTTLLPQWDKCVNFI	PHEX	396	P78562
ALQLPVVSQEWVIQC	TP53BP1	1936	Q12888
NLLVCPKTTIWNAQQ	PKHD1L1	3871	Q86WI1
PKTTIWNAQQKHCEL	PKHD1L1	3876	Q86WI1
LTNQWAVTNPKDVLV	SYNGR2	126	O43760
QQDACLILVKGNWTT	nan	21	Q96IR3
INNWIVQLSKIIPDC	USF2	251	Q15853
CQQWLQPETHTKEQI	ZSCAN26	76	Q16670
CVPQFEKWLQDNLTI	TSPAN5	221	P62079
CNTPVKSELLWQTHV	ZNF830	56	Q96NB3
SQSIAIHEPQCLQKW	ZNF474	106	Q6S9Z5
RTVKLVPWSQCLQNF	WSB1	56	Q9Y6I7
KLIQPHVQASNNCWE	VEZT	476	Q9HBM0
IPNNVKLQCVSWNKE	WDR35	11	Q9P2L0
SQCQEWLILSTQVPG	ZNF214	101	Q9UL59
NNWIVQLSKIIPDCS	USF1	216	P22415
TQKLETVWLSGICQN	GRIN2C	786	Q14957
PNLWKSEDITQIVAN	NMNAT1	166	Q9HAN9